CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to 4519.T

Ifosfamide or dacarbazine

Phase 3
Chugai Pharmaceutical Co., Ltd. (4519.T)

Phase 3

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Dec '26
4519.TPhase 3

Ifosfamide or dacarbazine Phase 3 Est. Readout

Ifosfamide or dacarbazine
Dec 2026~
CT.gov
00%
Competitive Landscape

0 competitors in Non-metastatic Soft-tissue Sarcoma

View Full Landscape
Drug Information

Target Indication

Non-metastatic Soft-tissue Sarcoma

Clinical Trial

NCT03805022

Last updated: 8/15/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.